The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ASSEMBLY BIOSCIENCES INC | COM | 045396908 | 5,807 | 148,100 | SH | Call | SOLE | 148,100 | 0 | 0 | |
ASCENDIS PHARMA A S | COM | 04351P901 | 17,096 | 257,000 | SH | Call | SOLE | 257,000 | 0 | 0 | |
ASCENDIS PHARMA A S | COM | 04351P901 | 12,639 | 190,000 | SH | Call | SOLE | 190,000 | 0 | 0 | |
CELGENE CORP | COM | 151020904 | 15,884 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
CELGENE CORP | COM | 151020904 | 30,577 | 385,000 | SH | Call | SOLE | 385,000 | 0 | 0 | |
FIBROGEN INC | COM | 31572Q908 | 21,910 | 350,000 | SH | Call | SOLE | 350,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558903 | 20,728 | 292,600 | SH | Call | SOLE | 292,600 | 0 | 0 | |
IRONWOOD PHARMACEUTICALS INC | COM | 46333X908 | 11,044 | 577,600 | SH | Call | SOLE | 577,600 | 0 | 0 | |
ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 11,001 | 3,887,407 | SH | SOLE | 3,887,407 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 3,048 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 115,401 | 2,943,164 | SH | SOLE | 2,943,164 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 36,274 | 2,961,147 | SH | SOLE | 2,961,147 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 12,682 | 1,039,500 | SH | SOLE | 1,039,500 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 126,280 | 2,017,250 | SH | SOLE | 2,017,250 | 0 | 0 | ||
IMMUNE DESIGN CORP | COM | 45252L103 | 20,191 | 4,437,600 | SH | SOLE | 4,437,600 | 0 | 0 | ||
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 787 | 412,000 | SH | SOLE | 412,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 119,501 | 6,250,073 | SH | SOLE | 6,250,073 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 9,975 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 71,065 | 3,904,675 | SH | SOLE | 3,904,675 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 29,955 | 1,450,606 | SH | SOLE | 1,450,606 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 55,798 | 199,500 | SH | SOLE | 199,500 | 0 | 0 | ||
ONCONOVA THERAPEUTICS INC | COM | 68232V306 | 3,034 | 7,500,000 | SH | SOLE | 7,500,000 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 21,437 | 1,509,671 | SH | SOLE | 1,509,671 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | COM | Y95308105 | 15,792 | 412,871 | SH | SOLE | 412,871 | 0 | 0 | ||
APTINYX INC | COM | 03836N103 | 992 | 41,037 | SH | SOLE | 41,037 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 27,373 | 2,236,387 | SH | SOLE | 2,236,387 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 4,945 | 450,400 | SH | SOLE | 450,400 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 22,009 | 1,272,198 | SH | SOLE | 1,272,198 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 20,764 | 1,538,088 | SH | SOLE | 1,538,088 | 0 | 0 | ||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 41,670 | 2,671,161 | SH | SOLE | 2,671,161 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 14,529 | 890,808 | SH | SOLE | 890,808 | 0 | 0 | ||
UNITY BIOTECHNOLOGY INC | COM | 91381U101 | 25,310 | 1,680,644 | SH | SOLE | 1,680,644 | 0 | 0 | ||
ERYTECH PHARMA | SPONSORED ADR | 29604W108 | 1,734 | 153,964 | SH | SOLE | 153,964 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 97,390 | 1,464,067 | SH | SOLE | 1,464,067 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 5,750 | 298,100 | SH | SOLE | 298,100 | 0 | 0 |